Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,213 | 97 | 84.0% |
| Education | $231.68 | 3 | 16.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $684.25 | 64 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $177.45 | 7 | $0 (2018) |
| Shire North American Group Inc | $149.88 | 3 | $0 (2017) |
| Allergan Inc. | $120.14 | 7 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $72.83 | 5 | $0 (2018) |
| Vanda Pharmaceuticals Inc. | $53.22 | 3 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $46.63 | 3 | $0 (2017) |
| Lundbeck LLC | $46.17 | 3 | $0 (2018) |
| Neos Therapeutics, LP | $36.52 | 2 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.77 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $60.05 | 3 | Allergan Inc. ($60.05) |
| 2018 | $611.21 | 45 | Sunovion Pharmaceuticals Inc. ($326.60) |
| 2017 | $773.79 | 52 | Sunovion Pharmaceuticals Inc. ($357.65) |
All Payment Transactions
100 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: NEUROSCIENCE | ||||||
| 04/26/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $6.78 | General |
| Category: Central Nervous System | ||||||
| 11/09/2018 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $111.20 | General |
| 11/09/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Central Nervous System | ||||||
| 10/19/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Central Nervous System (CNS) | ||||||
| 08/20/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $9.05 | General |
| Category: CNS | ||||||
| 08/13/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $10.17 | General |
| Category: CNS | ||||||
| 08/06/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $8.71 | General |
| Category: CNS | ||||||
| 07/30/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: CNS | ||||||
| 07/23/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: CNS | ||||||
| 07/16/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $7.90 | General |
| Category: CNS | ||||||
| 07/09/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: CNS | ||||||
| 06/25/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: CNS | ||||||
| 06/22/2018 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 06/18/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: CNS | ||||||
| 06/11/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $10.29 | General |
| Category: CNS | ||||||
| 06/08/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: Central Nervous System | ||||||
| 06/08/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Education | In-kind items and services | $7.53 | General |
| Category: Central Nervous System | ||||||
| 06/04/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $9.58 | General |
| Category: CNS | ||||||
| 05/25/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: CNS | ||||||
| 05/21/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $9.88 | General |
| Category: CNS | ||||||
| 05/14/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $10.04 | General |
| Category: CNS | ||||||
| 05/09/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $6.54 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 44 | 94 | $19,015 | $6,027 |
| 2022 | 2 | 53 | 130 | $23,275 | $7,958 |
| 2021 | 2 | 56 | 178 | $34,630 | $12,145 |
| 2020 | 2 | 70 | 188 | $35,630 | $9,914 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 53 | $12,455 | $4,073 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 41 | $6,560 | $1,954 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 97 | $15,520 | $5,027 | 32.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 33 | $7,755 | $2,931 | 37.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 82 | $19,270 | $6,871 | 35.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 96 | $15,360 | $5,274 | 34.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 26 | 74 | $17,390 | $5,380 | 30.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 44 | 114 | $18,240 | $4,534 | 24.9% |
About Dr. Franc Strgar, M.D
Dr. Franc Strgar, M.D is a Psychiatry healthcare provider based in Eugene, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255398731.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Franc Strgar, M.D has received a total of $1,445 in payments from pharmaceutical and medical device companies, with $60.05 received in 2019. These payments were reported across 100 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,213).
As a Medicare-enrolled provider, Strgar has provided services to 223 Medicare beneficiaries, totaling 590 services with total Medicare billing of $36,044. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Eugene, OR
- Active Since 04/27/2006
- Last Updated 09/10/2013
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1255398731
Products in Payments
- LATUDA (Drug) $684.25
- VYVANSE (Drug) $129.04
- VRAYLAR (Drug) $120.14
- REXULTI (Drug) $79.88
- Fanapt (Drug) $53.22
- AUSTEDO (Drug) $52.22
- BELSOMRA (Drug) $43.19
- Trintellix (Drug) $23.77
- MYDAYIS (Drug) $20.84
- Cotempla XR-ODT (Drug) $19.38
- Vivitrol 380 mg (Drug) $18.83
- Adzenys XR-ODT (Drug) $17.14
- NUEDEXTA (Drug) $15.36
- SD809-TD (Drug) $14.03
- ABILIFY MAINTENA (Drug) $12.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Eugene
Dr. John Lipkin, M.d, M.D
Psychiatry — Payments: $15,260
Dr. Hernan Schmidt, M.d, M.D
Psychiatry — Payments: $6,567
Victor Richenstein, Md, MD
Psychiatry — Payments: $5,106
Veronica Alfero, Md, MD
Psychiatry — Payments: $2,017
Dr. Russell Geoffrey, Md, MD
Psychiatry — Payments: $1,378
Dr. Harold Whiteley, M.d, M.D
Psychiatry — Payments: $1,215